MedTrace Logo

A Pilot Clinical Trial Of Memantine for Essential Tremor

NCT00439699 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2012-06-22

No results posted yet for this study

Summary

The purpose of this study is to obtain information on whether or not the medication Memantine reduces tremor in persons with essential tremor and is well-tolerated.

Conditions

Interventions

DRUG

Memantine

Mematine administration

Sponsors & Collaborators

  • Ralph M. Parsons Foundation

    collaborator OTHER

  • Forest Laboratories

    collaborator INDUSTRY

  • VA Greater Los Angeles Healthcare System

    lead FED

Principal Investigators

  • Adrian Handforth, M.D. · Veteran Affairs Greater Los Angeles

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00439699 on ClinicalTrials.gov